Evidence map›Paper›PMID 34206382›Full record

ArticleInternational journal of molecular sciences2021

Emerin Represses STAT3 Signaling through Nuclear Membrane-Based Spatial Control.

Byongsun Lee, Seungjae Lee, Younggwang Lee, Yongjin Park, Jaekyung Shim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Role of LMO7 in cancer (Review).Oncology reports · 2024
    Review
  5. Article
  6. Article
  7. Molecular Mechanisms for the Regulation of Nuclear Membrane Integrity.International journal of molecular sciences · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Byongsun LeeDepartment of Bioresources Engineering, Sejong University, Seoul 05006, Korea.
Seungjae LeeDepartment of Bioresources Engineering, Sejong University, Seoul 05006, Korea.
Younggwang LeeDepartment of Bioresources Engineering, Sejong University, Seoul 05006, Korea.
Yongjin ParkDepartment of Bioresources Engineering, Sejong University, Seoul 05006, Korea.
Jaekyung ShimDepartment of Bioresources Engineering, Sejong University, Seoul 05006, Korea.ORCID 0000-0002-7643-9234
Sejong University · KR

Funding

National Research Foundation of Korea NRF-2017R1D1A1B03034519National Research Foundation of Korea NRF-2018R1A6A3A01012433National Research Foundation of Korea NRF-2019R1I1A1A 01041000
6 · The paper itself

Abstract

Emerin is the inner nuclear membrane protein involved in maintaining the mechanical integrity of the nuclear membrane. Mutations in EMD encoding emerin cause Emery-Dreifuss muscular dystrophy (EDMD). Evidence is accumulating that emerin regulation of specific gene expression is associated with this disease, but the exact function of emerin has not been fully elucidated. Here, we show that emerin downregulates Signal transducer and activators of transcription 3 (STAT3) signaling, activated exclusively by Janus kinase (JAK). Deletion mutation experiments show that the lamin-binding domain of emerin is essential for the inhibition of STAT3 signaling. Emerin interacts directly and co-localizes with STAT3 in the nuclear membrane. Emerin knockdown induces STAT3 target genes

Indexed as

Signal TransductionA549 CellsCell NucleusCell SurvivalGene Expression RegulationHumansJanus KinasesMembrane ProteinsMuscle, SkeletalMuscular DystrophiesMutationNuclear EnvelopeNuclear ProteinsProtein BindingSTAT3 Transcription FactorTranscription FactorsemerinJanus KinasesMembrane ProteinsNuclear ProteinsSTAT3 protein, humanSTAT3 Transcription FactorTranscription FactorsemerinJAKmuscular dystrophySTAT3

Identifiers

PMID34206382
PMCPMC8269395
OpenAlexW3161455995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.